These results suggest that Osr1 inhibits the development of NAFLD by regulating liver inflammation through the PI3K/AKT/mTOR, NF-κB, and JNK signaling pathways. Here, MAPK8 is linked to metabolic dysfunction-associated steatotic liver disease.